IHH Annual Report 2023

Financial Statements Notes to the Financial Statements Name of subsidiary Place of incorporation and business Principal activities Effective ownership interest and voting interest 2023 % 2022 % Indirect subsidiaries (continued) Held through Fortis Hospitals Limited: (continued) Stellant Capital Advisory Services Private Limited ##^ India Merchant banker 31.17 31.17 Fortis Global Healthcare (Mauritius) Limited ##^ Mauritius Investment holding 31.17 31.17 Held through Escorts Heart Institute and Research Centre Limited: Fortis Asia Healthcare Pte. Ltd. #^ Singapore Investment holding 31.17 31.17 Fortis Health Staff Limited ##^ India Dormant 31.17 31.17 Held through Fortis Asia Healthcare Pte. Ltd.: Fortis Healthcare International Pte. Ltd. #^ Singapore Dissolved during the year – 31.17 MENA Healthcare Investment Company Limited ##^ (15) British Virgin Islands Investment holding 25.73 – Held through Fortis Healthcare International Pte. Ltd.: MENA Healthcare Investment Company Limited ##^ (15) British Virgin Islands Investment holding – 25.73 Held through MENA Healthcare Investment Company Limited: Medical Management Company Limited ##^ British Virgin Islands Investment holding 25.73 25.73 Held through Fortis Malar Hospitals Limited: Malar Stars Medicare Limited #^ India Investment holding 19.55 19.55 Held through Stellant Capital Advisory Services Private Limited: RHT Health Trust Manager Pte. Ltd. ##^ Singapore Trustee-manager of a Business Trust 31.17 31.17 Held through Parkway Investments Pte. Ltd.: Gleneagles Medical Centre Ltd. # Singapore Dormant 100 100 Gleneagles Pharmacy Pte. Ltd. # Singapore Dormant 100 100 Mount Elizabeth Medical Holdings Limited # Singapore Investment holding 100 100 Parkway Life Real Estate Investment Trust # (14) Singapore Real estate investment trust 35.56 35.58 IHH Healthcare Berhad 242 41. SUBSIDIARIES (continued)

RkJQdWJsaXNoZXIy NDgzMzc=